Search

everythinglearnresearchcommunity

for

Search:↓

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Finasteride reduces sperm count and quality and alters hormone levels in mice.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

A 7-year-old boy with a brain tumor developed early puberty, which was successfully treated with medication.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

The Random Forest algorithm was the most accurate at diagnosing Polycystic Ovarian Syndrome.

Hormonal imbalances are a key cause of missed menstrual periods in women.

Testosterone therapy helps boys with hormone deficiencies develop normal male characteristics and grow properly.

Testosterone injections can cause skin darkening and thickening.

Nanotechnology improves Clomiphene citrate's effectiveness and reduces side effects for treating ovulatory disorders.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Centratherum anthelminticum seed extract effectively treats Polycystic Ovary Syndrome in rats.

The new rodent model successfully mimics non-lean human PCOS symptoms.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Resveratrol improved hormone levels, menstrual cycles, hair loss, and ovarian function in PCOS patients.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.